Edition:
United Kingdom

Neuralstem Inc (CUR.OQ)

CUR.OQ on NASDAQ Stock Exchange Capital Market

1.63USD
16 Feb 2018
Change (% chg)

$0.10 (+6.54%)
Prev Close
$1.53
Open
$1.52
Day's High
$1.65
Day's Low
$1.48
Volume
33,962
Avg. Vol
187,708
52-wk High
$6.58
52-wk Low
$0.89

Chart for

About

Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189... (more)
No analyst recommendations are available for .

Overall

Beta: 1.58
Market Cap(Mil.): $16.36
Shares Outstanding(Mil.): 12.12
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Neuralstem Q3 loss per share $0.01

* Neuralstem reports third quarter 2017 fiscal results and provides clinical and business update

13 Nov 2017

BRIEF-Neuralstem Inc appoints two members to its board

* Neuralstem announces the appointment of two new members to the board of directors

25 Sep 2017

BRIEF-Neuralstem Inc gets two additional U.S. patents

* Neuralstem Inc - ‍been awarded two additional patents by United States Patent and Trademark Office​ Source text for Eikon: Further company coverage:

07 Sep 2017

Earnings vs. Estimates